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Members of the diazeniumdiolate class of natural compounds show potential for drug
development because of their antifungal, antibacterial, antiviral, and antitumor activities. Yet,
their biosynthesis has remained elusive to date. Here, we identify a gene cluster directing the
biosynthesis of the diazeniumdiolate compound fragin in Burkholderia cenocepacia H111. We
provide evidence that fragin is a metallophore and that metal chelation is the molecular basis
of its antifungal activity. A subset of the fragin biosynthetic genes is involved in the synthesis
of a previously undescribed cell-to-cell signal molecule, valdiazen. RNA-Seq analyses reveal
that valdiazen controls fragin biosynthesis and affects the expression of more than 100
genes. Homologs of the valdiazen biosynthesis genes are found in various bacteria, sug-
gesting that valdiazen-like compounds may constitute a new class of signal molecules. We
use structural information, in silico prediction of enzymatic functions and biochemical data to
propose a biosynthesis route for fragin and valdiazen.
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Members of the Burkholderia cepacia complex (Bcc), agroup of 20 closely related species1, are importantopportunistic human pathogens, but are also capable of
synthesizing various bioactive secondary metabolites that sup-
press fungal and bacterial pathogens2,3. Many of these bioactive
secondary metabolites are synthesized by multi-enzyme machi-
neries, such as polyketide synthases (PKS) and non-ribosomal
peptide synthetases (NRPS)4,5, which are often encoded in large
gene clusters together with tailoring enzymes, regulators, and
transporters6,7.
Previous work has shown that in many Burkholderia strains the
production of antibiotic secondary metabolites is regulated by N-
acyl homoserine lactone (AHL)-dependent quorum sensing (QS)
systems. The CepIR QS system, which is present in all Bcc species,
controls the production of diverse antifungal compounds,
including pyrrolnitrin in Burkholderia lata, B. ambifaria, and B.
pyrrocinia8, and enacyloxin and an occidiofungin-like cluster also
found in B. ambifaria9,10. Antifungal activity of many Bcc strains
is also dependent on the presence of megaplasmid pC3, the third
replicon present in all Bcc species11. This replicon was shown to
carry the biosynthesis gene clusters directing the production of
occidiofungin12, enacyloxin9, and pyrrolnitrin8. Moreover, the afc
gene cluster, which encodes a lipopeptide antibiotic of unknown
structure13, is present on pC3 in B. pyrrocinia, B. lata 383,
B. ambifaria AMMD, as well as many sequenced B. cenocepacia
strains11. The strain used in this study, B. cenocepacia H111,
exhibits strong antifungal activity that is dependent on the pre-
sence of pC311,14 and is under the control of the CepIR QS
system8. A bioinformatic analysis revealed that this strain does
not harbor any known antifungal determinants, except for the afc
cluster on pC3. However, in contrast to other Bcc strains, the afc
cluster in H111 does not contribute to antifungal activity of the
strain15. Hence, neither the genes directing the biosynthesis of the
antifungal agent produced by H111 nor its structure are known.
In this study, we demonstrate that the major antifungal com-
pound produced by B. cenocepcia H111 is the unusual diazo-
niumdiolate compound (−)-fragin (1). We identify the genes
directing the biosynthesis of this natural compound and, on the
basis of structural information, in silico prediction of enzymatic
functions and biochemical data, we propose a model for its bio-
synthesis. We also show that a subset of the genes for fragin
biosynthesis is responsible for the production of a novel signal
molecule, valdiazen (2), which not only positively autoregulates
its own and fragin biosynthesis, but is a global regulator of more
than 100 genes in B. cenocepacia H111. Valdiazen appears to be
the ﬁrst member of a new class of signal molecules, as valdiazen
biosynthesis gene homologs are found in various bacteria.
Results
Identiﬁcation of the ham gene cluster. The ability of B. cen-
ocepacia strain H111 to suppress fungal growth depends on the
presence of the megaplasmid pC311,15 and an intact CepIR QS
system8. In agreement with our previous work8,11,15, we show
that the antifungal activities of the cepI mutant and the pC3-null
strain are markedly reduced relative to the wild type (Supple-
mentary Fig. 1) and that inactivation of the afcA gene, which is
part of the afc gene cluster located on pC3, does not affect
antifungal activity of B. cenocepacia H111 (Supplementary Fig. 2).
This suggests that, for reasons that are unknown, the afc cluster
does not contribute to the antibiotic activity of B. cenocepacia
H111, while it is the major antifungal determinant in B. pyrro-
cinia13 and contributes to anitfungal activity of B. cenocepacia
K56-216. To identify candidate genes for the biosynthesis of the
unknown antifungal agent produced by strain H111, we com-
pared the transcriptomes of the QS mutant B. cenocepacia
H111ΔcepR and the ΔpC3 derivative with the transcriptome of
the H111 parental strain11,17. A non-ribosomal peptide synthe-
tase (NRPS) gene cluster consisting of seven genes was down-
regulated in both the ΔcepR and the ΔpC3 mutant
(Supplementary Table 1). This gene cluster is organized in two
oppositely oriented operons, comprising ﬁve
(I35_4191–I35_4195) and two genes (I35_4188 and I35_4189),
which we named hamABCDE (H111 antifungal metabolite) and
hamFG, respectively (Fig. 1a). The NRPS-like protein HamD
consists of an adenylation (A) domain, a thiolation (T) domain,
and a reductase (R) domain. HamF encodes a free standing
starter condensation (C) domain. Starter C domains are a recently
characterized subtype of C domains, which do not catalyze pep-
tide bond formation, but acylate L-amino acids18. Protein domain
analysis of the remaining ﬁve genes in the ham cluster suggested
that they are tailoring enzymes. HamA encodes a heme-like
oxygenase. HamB contains an RmlC-like cupin domain, which
likely acts as an epimerase or dioxygenase. The hamC gene
encodes a p-aminobenzoate N-oxygenase, known as AurF, which
catalyzes the conversion of p-aminobenzoate (PABA) to p-
nitrobenzoate (PNBA)19. HamE is predicted to encode a poly-
ketide cyclase/dehydrase. The last gene in the ham cluster, hamG,
encodes an aminotransferase that most likely adds an amino
group to the biosynthetic product of the ham cluster (Fig. 1b). An
Starter condensation domain Adenylation domain Thiolation domain Reductase domain
HamF HamEHamA HamB HamCHamG HamD
Protein name Protein domain InterProScan number
HamA Haem-oxygenase-like, multi-helical IPR016084
HamB RmlC-like cupin domain superfamily IPR011051
HamC p -aminobenzoate N -oxygenase AurF IPR025859
HamE Polyketide cyclase/dehydrase IPR019587
HamG Aminotransferase class-III IPR005814
C
C A T R
A T R
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b
Fig. 1 Genetic organization and protein domain predictions of the ham genes. a The ham cluster is organized into two divergently orientated operons. hamD
encodes an adenylation domain, a thiolation domain and a reductase domain. hamF encodes a starter condensation domain. b Predictions of protein
domains and their corresponding InterProScan numbers are shown for the ﬁve putative tailoring enzymes of the ham cluster
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architecture search of the ham cluster with the MultiGeneBlast
software20 showed that homologs of the ham cluster are present
in several B. cenocepacia strains and in Burkholderia cepacia DDS
7H-2 (Supplementary Data 1). The hamABCDE operon is also
fully conserved in Burkholderia plantarii ATCC 43733, Bur-
kholderia glumae PG1, Pseudomonas aeruginosa PA7, and Pseu-
domonas ﬂuorescens strain X. A homologous operon that lacks
hamB is present in Burkholderia sp. CCGE1003 and various
Pseudomonas and Pandoraea species. The genomes of Pandoraea
vervacti NS15 and Pseudomonas trivialis IHBB745 contain
homologs of hamA, hamC and hamE and homologs of hamC and
hamE are present in the genome of Pandoraea oxalativorans
DSM23570 (Supplementary Data 1).
We also analyzed the genes in the immediate vicinity of the
ham clusters. In eight out of nine Burkholderia strains, genes
encoding an AraC-type regulator (CepS), a LuxR-type regulator
(CepR2) and a 2-isopropylmalate dehydrogenase (LeuA) are
located upstream of the ham cluster. In these strains, the
downstream genes are also conserved and encode a LysR-type
regulator and a RND-efﬂux pump. The B. cenocepacia strains and
B. cepacia DDS 7H-2 encode a second AraC-type regulator
downstream of the ham cluster (Supplemenatry Fig. 3a). Three
genes in the downstream region of the ham clusters in the
Pandoraea strains are conserved and encode a LysR-type
regulator, a Fis regulator and an aldo/keto reductase. Most
interestingly, a gene encoding a 2-aminoadipate aminotransferase
is located immediately downstream of hamE and appears to be
part of the hamABCDE operon in seven of the eight Pandoraea
strains (Supplementary Fig. 3b). The genetic organization up- and
downstream of the ham clusters in the Pseudomonas strains is
highly variable. Only one gene, which codes for a GntR regulator,
is often found in the vicinity of these ham operons (Supplemen-
tary Fig. 3c).
The ham cluster directs the biosynthesis of fragin. To investi-
gate the importance of the ham cluster for antifungal activity of B.
cenocepacia H111, in-frame deletion mutants of hamD and hamF
and respective in trans-complemented derivatives were tested for
their activity against the fungus Fusarium solani. Both mutants
lost their antifungal activity against F. solani, while the com-
plemented strains showed activities similar to that of the wild
type (Fig. 2a). To ascertain the importance of individual ham
genes for antifungal activity, we employed a F. solani spray assay.
Inactivation of any of the seven genes of the ham cluster abol-
ished antifungal activity (Fig. 2b; Supplementary Fig. 4). We
noticed that in these assays the fungus produced a brownish
pigment around the bacterial colonies, which may reﬂect a stress
response of the fungus, possibly because of nutrient depletion or
metabolites released by the bacteria. Expression of the wild-type
ham alleles from a plasmid in their respective mutant background
rescued antifungal activity to varying degrees (Fig. 2b; Supple-
mentary Fig. 4). This suggests that all genes of the ham cluster are
required for full antifungal activity.
Bioassay-guided fractionation by HPLC-MS was performed on
chloroform extracts of culture supernatants of the wild-type H111
to identify the antifungal compound. A bioactive compound
eluting with a retention time of 20.4 min was detected in the wild-
type extract, but was missing in the extract of the hamD mutant
(H111 ΔhamD) (Supplementary Fig. 5a and b). The MS spectrum
of this compound displayed an m/z of 274.2 Da (positive mode)
and an m/z of 272.2 Da (negative mode) suggesting a molecular
mass of 273.2 Da. An additional major fragment (m/z of 244.2 Da,
positive mode) was detected, which could originate via a loss of
nitric oxide from the parent compound. The constitution of the
compound was further investigated by 1H-NMR spectroscopy.
The 1H 1H COSY correlations between H-1 to H-2, H-2 to H-3,
H-3 to H-4 and H-4 to NH were assigned to the core structure of
the left part of the compound and those between H-6 to H-7, H-7
to H-(8-11) and H-(8-11) to H-12 were assigned to the core
structure of the right part (Supplementary Table 2; Supplemen-
tary Note 1). The presence of a diazeniumdiolate functional group
was inferred on the basis of the shift of H-3 at 4.2 ppm and C-3 at
78.0 ppm, indicating an electron-withdrawing group attached to
C-3. A non-correlating de-shielded proton at 11.72 ppm, in
addition to an ESI-MS fragment displaying a loss of 30 Da,
constituted further evidence for the presence of a diazeniumdio-
late group. These spectroscopic data are in full agreement with
the structure of fragin, an antifungal compound, which was
isolated from the culture supernatant of Pseudomonas fragi in
196721. The absolute conﬁguration of neither (+)- nor (−)-fragin
has been reported in the literature, although the crystal structure
of racemic fragin is known22, and therefore we carried out an
enantioselective total synthesis starting from enantiopure Fmoc-
protected D- and L-valine (Fig. 3; Supplementary Note 1). First,
the carboxylic acid (3a or 3b) was reduced to the alcohol (4a or
4b)23, followed by a Mitsunobu reaction and subsequent
reduction of the azide, which furnished the ammonium salt (6a
or 6b). Acylation (to give 7a and 7b), Fmoc-removal by AlCl324
proceeded in excellent yields and a simple acidic and basic
extraction was sufﬁcient to obtain the primary amine (8a or 8b)
in pure form. The hydroxylamines (10a and 10b) were obtained
via a two-step procedure using dibenzoylperoxide, followed by
cleavage of the benzoyl moiety in 9 in the presence of hydrazine.
Isopentyl nitrite under basic conditions delivered ﬁnally
enantiopure (−)-fragin (1) and (+)-fragin (11) in 83% yield
(Fig. 3a). The absolute conﬁguration of fragin was unambiguously
assigned as (R) by comparison of the optical rotation values of
synthetic and isolated compounds. X-ray crystallographic
analysis of the natural product (−)-fragin (1) further corrobo-
rated this conﬁguration (Fig. 4a; Supplementary Fig. 6). On the
basis of quantitative HPLC, we estimated the concentration
of fragin in the wild-type culture supernatant to be 69 µg/ml
(253 µM).
Both fragin enantiomers showed good activity against F. solani
(Fig. 4b), yeast and Gram-positive bacteria, but only negligible
inhibition of Gram-negative bacteria (Supplementary Fig. 7a–c).
Fragin production is positively auto-regulated. We hypothe-
sized that expression of the ham genes may be under control of a
self-generated signal, as the homologous gene clusters of Pseu-
domonas syringae pv. syringae UMAF0158 (mgo) and Pseudo-
monas entomophila (pvf) (both of which lack hamB as well as the
hamFG operon) (Supplementary Data 1) were shown previously
to synthesize an extracellular signal molecule of unknown
structure25,26. To test this possibility, we constructed a tran-
scriptional fusion of the hamA promoter (PhamA) to lacZ (PhamA–
lacZ) and introduced it into H111 wild type and H111 ΔhamD.
The promoter activity was markedly reduced in the ΔhamD
mutant relative to the wild-type strain when tested on agar plates
(Supplementary Fig. 8a). Importantly, when the wild-type strain
was streaked next to H111 ΔhamD/PhamA–lacZ, the activity of the
hamA promoter was restored, suggesting that the molecule is
secreted and is used for cell-to-cell signaling (Fig. 5a). To ascer-
tain the genes required for the synthesis of the signal molecule, we
tested all ham mutants for induction of H111 ΔhamD/PhamA–
lacZ in cross-streak experiments (Fig. 5a). In full agreement with
work on the mgo and pvf clusters of P. syringae pv. syringae and
P. entomophila, respectively, we found that hamB, hamF, and
hamG are dispensable for the synthesis of the signal. Given that
the hamFG operon is required for fragin biosynthesis (Fig. 2b), we
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concluded that fragin cannot be responsible for induction of the
hamA promoter, implying that the ham cluster directs the
synthesis of two distinct molecules. We speculated that the two
molecules may have similar structures and that fragin is likely to
mask the presence of the signal. We therefore chose the ΔhamF
mutant to elucidate the structure of the signal molecule. The
crude extract of the ΔhamF mutant was puriﬁed by HPLC after a
basic-acid workup and a compound, eluting with a retention time
of 10.2 min, was isolated that activated hamA promoter activity
(Supplementary Fig. 9). 1H and 13C NMR spectroscopy analysis
revealed that the structure of the compound, which we named
valdiazen (2) (Fig. 5b), possesses, as (−)-fragin (1), the
characteristic proton and carbon chemical shifts of an isopropyl
and diazeniumdiolate group. Comparing the NMR spectra of the
two natural products we propose that valdiazen has a hydroxy
group at C4, due to a higher chemical shift (61.2 ppm instead of
39.1 ppm) (Supplementary Tables 2 and 3; Supplementary
Note 2). The structure of valdiazen was conﬁrmed by synthesis
and an X-ray crystal structure analysis of synthesized (−)-val-
diazen (12), although the latter did not independently conﬁrm
the absolute conﬁguration (Supplementary Fig. 10). Furthermore,
the presence of the two enantiomers of the natural product val-
diazen was determined by chiral HPLC measurements using
synthetic 12 and 13 as standards (Supplementary Fig. 11).
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Fig. 2 Antifungal activity is dependent on fragin, the biosynthetic product of the ham gene cluster. a Antifungal activity of the wild type (H111 wt), the hamD
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Quantitative HPLC revealed that the concentration of valdiazen
in the wild-type culture supernatant is 3.3 µg/ml (22 µM).
Valdiazen is a novel quorum sensing signal. To conﬁrm that
valdiazen stimulates the activity of the hamA promoter and to test
whether the hamFG operon is also regulated by valdiazen, we
measured β-galactosidase activities of respective transcriptional
lacZ promoter fusions in the wild type, as well as in a ΔhamD
(fragin and valdiazen negative) and a ΔhamF (fragin negative and
valdiazen positive) mutant background. The activities of the two
promoters were virtually indistinguishable between the wild type
and the ΔhamF mutant but they were greatly reduced in the
ΔhamD mutant (Fig. 5c; Supplementary Fig. 8b). We also mea-
sured the hamA promoter activity over the growth curve and
observed that its expression is strongly induced at the late
exponential phase (Supplementary Fig. 12), indicating that pro-
duction of valdiazen is induced at high cell densities, which is a
typical feature of QS signals. Addition of (−)-valdiazen to the
growth medium restored β-galactosidase activities in the ΔhamD
mutant background in a dose-dependent manner, reaching the
level of the wild type at a concentration of 50 µM (Fig. 5c; Sup-
plementary Fig. 8b). These results demonstrate that valdiazen is a
novel signal molecule that positively regulates its own production.
In contrast, addition of (−)-fragin did not induce the hamA
promoter (Fig. 5c). We also tested the ability of valdiazen to
inhibit growth of the fungus F. solani and a panel of selected
bacteria, but could only observe a slight inhibition of Gram-
negative bacteria at the highest concentration (128 µg/ml) (Sup-
plementary Fig. 13a and b). This shows that despite their struc-
tural similarity, fragin and valdiazen have two distinct biological
functions.
To identify the valdiazen regulon, we performed RNA-Seq
analyses of the wild-type strain H111 and the isogenic ΔhamD
mutant in the absence or presence of 50 µM (−)-valdiazen.
Expression of 77 genes was more than threefold reduced in the
b
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Fig. 4 Activities of (−)-fragin (1) and (+)-fragin (11). a Structure of (−)-fragin (1). b Disc diffusion assays of synthetic (−)- and (+)-fragin to determine
the antifungal activity. Representative pictures of an antifungal spray assay against the fungus F. solani are shown. Scale bar indicates 10 mm
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H111 ΔhamD mutant relative to the wild type (Supplementary
Data 2). Among the strongest regulated genes was a cluster of
sixteen genes consisting of the two ham operons along with genes
in their vicinity. These valdiazen-activated genes code for CepR2
(I35_4186), CepS (I35_4187), a LysR-type regulator (I35_4196), a
LeuA homolog (I35_4185), a tripartite multidrug resistance
system (I35_4198 – I35_4200), a hypothetical protein
(I35_4201), and a TRP repeat protein (I35_4202). Valdiazen also
positively regulated the expression of genes that are not physically
connected to the ham cluster.
Of notable interest are four genes predicted to be involved in
metal homeostasis, encoding a metal transporting ATPase
(I35_0057), the ECF sigma factor regulating the ornibactin
cluster (I35_1599)27, a hemin uptake protein (I35_2223), and
PchE (I35_6121), an NRPS enzyme involved in pyochelin
biosynthesis28. In addition, two LeuA-like genes (I35_4185,
I35_2881) and an ilvD homolog (I35_2532) are positively
regulated by valdiazen. These three genes are involved in the
metabolism of the branched chain amino acids leucine and valine.
Furthermore, several genes encoding for proteins which use
metals as co-factors are also positively regulated by valdiazen
(I35_2533, I35_4763, I35_4764, I35_0589). We also identiﬁed 30
genes showing signiﬁcant up-regulation in the H111 ΔhamD
mutant compared to the wild type (fold-change > 3 and p-value <
0.05; Supplementary Data 3). Among these are several genes
involved in metal homeostasis, including the ornibactin biosynth-
esis cluster (I35_1607–I35_1614), the zinc regulator zur
(I35_2669) and a zinc ABC transporter (I35_2670 – I35_2671).
In addition, a hemin transport system (I35_6523–I35_6526) and
two neighbor genes (I35_6527 and I35_6528) are also upregulated
in the H111 ΔhamD mutant and therefore downregulated by
valdiazen.
Comparison of the transcriptome of the wild type with the
one of the ΔhamD mutant in the presence of 50 µM
valdiazen revealed that expression of 73 genes was signiﬁcantly
differentially regulated (Supplementary Data 4; Supplementary
Table 4). Among these, the pyochelin biosynthesis cluster
(I35_1827–I35_1832) was repressed (Supplementary Data 4).
These results suggest that valdiazen not only controls its own
biosynthesis and the production of fragin, but also affects valine
and leucine biosynthesis and regulates several genes involved in
metal homeostasis.
We validated our transcriptomics data by quantitative reverse
transcription PCR (qRT-PCR). Two ham genes (hamC and
hamG) as well as two genes positively regulated by valdiazen (ilvD
and leuA) and one gene negatively regulated (hmuT) were tested
(Supplementary Table 5). All four genes showed the same
regulation pattern as observed in the RNA-seq analysis.
The antifungal activity of fragin is due to metal chelation. We
observed that the antifungal activity of B. cenocepacia H111
decreased with increasing amounts of iron in the test plates
(Supplementary Fig. 14). In the presence of 10 μM iron, the
antifungal activity of the H111 wild type and the complemented
ΔhamD mutant was abolished. This effect was not due to
downregulation of ham gene expression, as high iron con-
centrations were found to stimulate hamA promoter activity
(Supplementary Fig. 15). This ﬁnding, together with the obser-
vation that many of the valdiazen-regulated genes are involved in
metal homeostasis or encode metal-dependent enzymes, sug-
gested that fragin may chelate metal ions and that the metal
complex has no antifungal activity. When fragin extracts were
spotted on antifungal test plates containing 100 μM iron, or were
pre-incubated with 100 µM iron prior to spotting on plates, a
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strong reduction of antifungal activity was observed (Supple-
mentary Fig. 16a and b).
Diazenium diolate compounds are known to chelate
metal ions and are best known for their ability to bind copper.
Reaction of synthetic (−)-fragin with Cu(OAc)2 in methanol
resulted in the formation of a fragin–copper complex, which was
analyzed by single-crystal X-ray crystallography (Supplementary
Fig. 17). The structure analysis showed that deprotonated fragin
ions (L) bind in a bidendate fashion to give square-planar cis-
CuIIL2 complexes with crystallographic C2 symmetry. The cis-
disposition of the diazeniumdiolate ligands is probably due to
electronic effects inﬂuencing their arrangement. The Cu–fragin
complex no longer exhibited antifungal activity (Supplementary
Fig. 16c), but still showed antibacterial activity against Gram-
positive bacteria (Supplementary Fig. 16d). To further evaluate
the mechanism of action, we subjected fragin to unbiased,
genome-wide proﬁling experiments using Saccharomyces cerevi-
siae heterozygous and homozygous deletion collections29,30.
Although heterozygous deletions (HIP) indicate targets and
pathways directly affected by the compound, homozygous
deletions (HOP) indicate synthetic lethality and compensating
pathways to those directly affected by the compound. The HIP
experiment did not identify strains with pronounced hypersensi-
tivity against fragin (Supplementary Fig. 18a). The best scoring
borderline hits were deletions in ISD11 and GRE1, both annotated
to be involved in regulation of iron metabolism31,32. In contrast
to the HIP proﬁle, the HOP experiment identiﬁed deletion strains
being considerably hypersensitive (Supplementary Fig. 18b). Best
scoring hits were AFT1 and MAC1 followed by PEX32 and ISU1.
AFT1 encodes the major transcription factor involved in
iron, and MAC1 in iron and copper utilization and home-
ostasis33,34. PEX32 encodes a peroxisomal component
linked to oxidative stress, while ISU1 is required for iron-
sulfur cluster assembly in mitochondria35,36. The notion that the
HIP proﬁle did not outline relevant hits in combination with
hypersensitive hits in HOP that are all linked to cation
metabolism suggests that fragin has no direct high afﬁnity
protein target. This supports the idea that its growth-inhibitory
effect is caused by its metal chelating properties, as this will result
in the inactivation of enzymes that use metal ions as co-factors.
This is in agreement with the abolished antifungal activity of
fragin in the presence of high iron concentrations and of the
synthetic Cu–fragin complex (Supplementary Fig. 16). The
persistent activity of the Cu–fragin complex against Gram-
positive bacteria, however, suggests that the antibacterial activity
of fragin relies on a different mode of action.
Biosynthesis of fragin and valdiazen. On the basis of our
enzyme predictions of the ham cluster (Fig. 1b), we speculated
that HamC is most likely involved in the transformation of the
amino group attached to the C3-atom of the NRPS-bound fragin/
valdiazen precursor to a diazeniumdiolate group, similar to the
conversion of p-aminobenzoic acid (PABA) to p-nitrobenzoic
acid (PNBA) described for AurF and PsAAO, which are HamC
homologs in Streptomyces thioluteus19,37 and Pseudomonas syr-
ingae pv. phaseolicola38, respectively. Indeed, puriﬁed HamC
(Supplementary Fig. 19) was found to oxidize PABA to PNBA
(Supplementary Fig. 20). We therefore speculated that the
nitrogen group of PNBA might subsequently be transferred to the
hydroxylamine precursor of fragin/valdiazen. A similar bio-
synthesis scheme has recently been reported for the biosynthesis
of cremeomycin39. To test whether the hydroxylamine precursor
of fragin can react with nitrite, potentially derived from PNBA or
a similar molecule, to form a diazeniumdiolate, we incubated the
precursor with Na15NO and analyzed the reaction products by
HPLC-MS. The formation of 15N-fragin along with an oxime as a
major decomposition product was observed (Supplementary
Fig. 21).
Discussion
In this study, we have identiﬁed an NRPS-like cluster in B. cen-
ocepacia H111, which synthesizes two distinct molecules, the
antifungal molecule (−)-fragin (1) and a novel signal molecule,
which we named valdiazen (2). Although fragin and valdiazen
share a high degree of structural homology, their biological
functions are different. Fragin was ﬁrst isolated in a screen for
plant growth inhibitors in 196721, but its biosynthesis, as well as
that of any other known diazeniumdiolate natural compound, has
remained elusive to date. In this study, we identiﬁed the genes
required for the biosynthesis of (−)-fragin and valdiazen and,
based on structural information, in silico prediction of enzymatic
functions and biochemical data, we propose a putative biosyn-
thetic route for these diazeniumdiolate compounds. In our model
the amino group of L-valine, which is bound to HamD, is oxidized
to a hydroxylamine by one of the tailoring enzymes, presumably
the putative heme-oxygenase HamA. The N-monooxygenase
HamC oxidizes the amino group of PABA (or of a related
compound) to a nitro group (Supplementary Fig. 20), as has been
demonstrated for the well-characterized homologs AurF and
PsAAO37. We postulate that the resulting compound serves as an
NO2 donor to provide the distal oxidized nitrogen of the diaze-
niumdiolate group. A similar reaction has recently been described
for the biosynthesis of cremeomycin, where L-aspartic acid is
oxidized to nitrosuccinic acid by the ﬂavin-dependent mono-
oxygenase CreE. β-elimination of nitrosuccinic acid by the action
of the CreD lyase releases nitrous acid, which then serves as the
NO donor in the ﬁnal diazotization step39. As HamE is essential
for the production of both (−)-fragin and valdiazen, we hypo-
thesize that this enzyme is also involved in the formation of the
diazeniumdiolate group. However, its exact role remains to be
determined. The branching point of valdiazen and (−)-fragin
biosynthesis is likely the reductive release of their shared pre-
cursor from the NRPS. We suggest that, similar to the bio-
synthesis of myxochelin40, the R-domain-catalyzed release of the
NRPS-bound amino acid proceeds in two 2-electron reduction
steps, which can competitively be transaminated during the sec-
ond reduction step by a transaminase. The ﬁrst R-domain cata-
lyzed 2-electron reduction results in an aldehyde intermediate,
which could undergo a second R-domain catalyzed 2-electron
reduction to yield valdiazen or, alternatively, could be transami-
nated by the transaminase HamG. The resulting amino derivative
of the latter reaction can then be acylated by HamF to yield
(−)-fragin (Fig. 6). We show that HamB is essential for antifungal
activity but not for the production of valdiazen. This suggests that
HamB catalyzes a reaction in the biosynthesis of fragin that is
downstream of the branching point of valdiazen and fragin in the
proposed biosynthesis route. However, additional experiments
will be required to determine its exact role in the biosynthetic
pathway.
Here, we demonstrate that valdiazen, which is synthesized by a
subset of the ham genes, is a diffusible signal that not only
autoregulates its own biosynthesis and that of fragin but also
affects expression of more than 100 genes (Fig. 5c, Supplementary
Fig. 8b, Supplementary Data 2 and 3). We also show that the
hamA promoter is strongly induced at the late exponential phase
(Supplementary Fig. 12), indicating that production of the signal
occurs at high cell densities. Taken together, valdiazen is diffu-
sible, can induce gene expression in neighboring cells, and is
produced in a population density-dependent manner. These
characteristics suggest that valdiazen represents a novel QS signal.
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Studies in P. syringae pv. syringae UMAF0158 and P. entomophila
have identiﬁed gene clusters (mgo and pvf, respectively) that
direct the biosynthesis of putative extracellular signal molecules.
These gene clusters show striking similarity to the hamABCDE
operon, but lack a hamB homolog, which is not required for
valdiazen biosynthesis. The mgo-derived signal molecule was
shown to regulate expression of the biosynthetic genes for man-
gotoxin production in P. syringae pv. syringae UMAF015825,
whereas pvf was shown to be involved in regulation of virulence
in P. entomophila26. Hence, valdiazen appears to be the prototype
of a new class of signal molecules that is used by members of the
genera Burkholderia, Pseudomonas, and Pandorea (Supplemen-
tary Fig. 3; Supplementary Data 1).
Among the most strongly valdiazen-regulated genes is the ham
gene cluster and surrounding genes, including several regulators
and a putative transporter system. This suggests that these genes
are potentially involved in the regulation of the ham genes and
the transport of either fragin or valdiazen. Further studies will be
required to clarify their involvement in fragin and valdiazen
production. The structures of fragin and valdiazen suggest valine
as their precursor. In this context it is interesting to note that our
transcriptomics data show a strong positive regulation of three
genes involved in the biosynthesis of valin and leucine (I35_2532,
I35_2881, and I35_4185). This suggests that valdiazen regulates
the production of amino acids that are likely precursors in the
biosynthesis of fragin and valdiazen. Valdiazen also regulates
expression of genes involved in metal homeostasis, including the
ornibactin biosynthesis cluster, a putative hemin uptake system
and a zinc uptake system with its associated regulator. Expression
of ~40% of the valdiazen-regulated genes could not be com-
plemented by the external addition of synthetic valdiazen
(Supplementary Data 2 and 3). The fact that the ΔhamD mutant
used in this experiment is unable to produce fragin, may indicate
that the observed effects on the expression of metal homeostasis
genes are indirect and are caused by the metallophore activity of
fragin.
Natural products bearing a diazeniumdiolate group are rarely
found in nature, but all of them show potent biological activities,
including antifungal, antibacterial, antiviral and antitumor
activities (reviewed in refs. 41,42), which makes this molecule
family a valuable source for drug development. Alanosine was
found to chelate copper and zinc43 and the synthetic diaze-
niumdiolate cupferron is commonly used as a copper
chelator44. Interestingly, mushroom tyrosinase, which uses cop-
per in its active center45, is inhibited by dopastin and cupfer-
ron46–48 and dopamin beta-hydroxylase, another copper-
dependent enzyme49, is also inhibited by dopastin50, whereas 5-
lipoxygenase, which has iron in its active center51, is inhibited by
nitrosoxacins A, B, and C52. Here we show that synthetic
(−)-fragin chelates copper with high afﬁnity and that the
resulting fragin-metal complex has no antifungal activity. Like-
wise, the antifungal activity of fragin is abolished in the presence
of high iron concentrations. Together with the results of the
chemogenomic proﬁling in yeast, this demonstrates that fragin is
a metallophore and that metal chelation is the molecular basis of
its antifungal activity. However, additional work will be required
to demonstrate unequivocally the mode of action against other
organisms.
Methods
Bacterial strains, plasmids and growth conditions. Strains and plasmids used in
this study are listed in Supplementary Table 6. Primers used in this study are listed
in Supplementary Data 5. All bacteria were routinely grown at 37 °C in broth (LB;
BDTmDifco, USA). For extraction of fragin and/or valdiazen, as well as promoter
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activity measurements, strains were grown in ABG minimal medium (component
A: 16 g (NH4)2SO4, 48 g Na2HPO4, 24 g KH2PO4, 24 g NaCl in 800 ml dH2O;
component B: 2 ml 1M MgCl2 × 6 H2O, 0.2 ml 500 mM CaCl2 × 2 H2O, 0.3 ml, 10
mM FeCl3 × 6 H2O in 800 ml dH2O; component G: 20% glycerol v/v in dH2O;
ABG: 100 ml component A, 800 ml component B and 100 ml component G). Yeast
extract (0.005%) was routinely added to boost growth except when the effect of
iron on the activity of the ham promoter was tested. S. cerevisae BY4741 was grown
in Yeast Peptone Dextrose (YPD) broth (BDTmDifco, USA) at 30 °C. Fusarium
solani strain DS185 was routinely grown on Malt Extract Agar (MEA)
(BDTmDifco, USA) plates at room temperature in the dark.
When required, media were supplemented with antibiotics at the following
concentrations: kanamycin (Km) at 100 µg/ml, gentamycin (Gm) at 20 µg/ml,
trimethoprim (Tp) at 25 µg/ml, chloramphenicol (Cm) 20 µg/ml.
Bacterial genetics. B. cenocepacia H111 mutants were constructed using three
different methods. PCR ampliﬁcation was carried out using the Phusion® High-
Fidelity DNA Polymerase (New England BiolabsInc). Mutation of hamG was
accomplished by single crossover. To this end an internal fragment of hamG was
PCR ampliﬁed using the primers listed in Supplementary Data 5 and cloned into
pSHAFT2Gm. The resulting plasmid was subsequently transferred into B. cen-
ocepacia H111 by tri-parental mating. Correct insertion into the chromosome was
veriﬁed by PCR.
Markerless mutations were either introduced using the pGPI-SceI/pDAI system
or a FRT/FLP-based system. Targeted unmarked deletions with the pGPI-SceI/
pDAI system were carried out as described previously53. In brief, upstream and
downstream regions (~1 kb in size), ﬂanking the region targeted for deletion, were
ampliﬁed using the primers listed in Supplementary Data 5. The PCR products
were digested with appropriate enzymes and puriﬁed with the QIAquick PCR
puriﬁcation kit (Qiagen, Germany). After triple ligation of pGPI-SceI with the two
homology arms upstream and downstream of the targeted deletion region, the
resulting plasmid was electroporated into E. coli SY327 and subsequently
transferred into B. cenocepacia strains by tri-parental mating. Correct integration of
the plasmid into the host genome was veriﬁed by PCR. To enforce a second
homologous recombination event, plasmid pDAI-SceI was transferred into the
target strain. Double crossover mutants were veriﬁed by PCR. Mutations in hamA,
hamB, and hamF were introduced by the aid of the pGPI-SceI/pDAI system. For
targeted unmarked deletions with the FRT/FLP system, upstream and downstream
regions of ~1 kb in size were ampliﬁed using the primers listed in Supplementary
Data 5. The PCR products were digested with the appropriate restriction enzymes
and puriﬁed with the QIAquick PCR puriﬁcation kit (Qiagen, Germany). The
upstream fragment was cloned into plasmid pSHAFT-FRT and electroporated into
E. coli CC118λpir. The downstream fragment was cloned into plasmid pEX-FRT
and electroporated into E. coli MC1061. Both resulting plasmids were sequentially
transferred into the target strain by conjugation. Integration of both plasmids into
the chromosome via homologous recombination was veriﬁed by PCR. Plasmid
pBBR5-FLP was introduced into the recipient and deletion of the targeted DNA
region was veriﬁed by PCR. Mutants carrying the deletion were subsequently
incubated on M9 minimal medium agar plates containing 10% sucrose as sole
carbon source to cure the strain from plasmid pBBR5-FLP. Mutations in hamC,
hamD, hamE, and afcA were generated by the aid of the FRT/FLP system.
In silico methods. Protein domains were analyzed with the NRPS/PKS analysis
tool54, NaPDoS (Natural Product Domain Seeker)55 and the InterProSCan 556
online tool.
The architecture search mode of the MultiGeneBlast20 software was used to
identify gene clusters similar to the ham cluster in other bacteria. The amino acid
sequences of all Ham proteins (HamA–HamG) were combined in one fasta ﬁle and
used for the search against a database created from the full bacterial GenBank
subdivision. All parameters of the MultiGeneBlast software were used with default
settings.
Dual-culture plate assay. F. solani was prepared by placing a fungal plug in the
middle of a MEA plate and incubated for 8 days at room temperature in the dark.
Bacteria from overnight LB cultures were pelleted, washed and adjusted to an
OD600 of 1. Three 10 µl samples of the bacterial suspension were spotted on MEA
plates equidistant from the center and the plates were allowed to dry for 10 min.
Following overnight incubation at 37 °C, plugs from the edge of 8 day old F. solani
plates were taken and placed in the center of the MEA plates with the spotted
bacteria. The plates were sealed with paraﬁlm and incubated for 8 days at room
temperature in the dark. Pictures were taken with a Nikon D90 camera with AF-S
Micro Nikkor 60 mm objective and used to determine the antifungal activity of
each bacterial strain. The distance between bacterial colonies and the fungus (mm)
was calculated from the pictures using the ImageJ software. Chemical com-
plementation of H111 ΔcepI was achieved by supplementing MEA plates with 200
nM C8-homoserine lactone (Fluka, Buchs, Switzerland).
Fungal spray assay. A single plug from an F. solani plate was incubated in a
shaking ﬂask containing 100 ml LB with 70 rpm shaking at room temperature for 2
to 3 days. The liquid F. solani culture was homogenized with glass beads by
thorough vortexing. Bacterial strains were grown overnight at 37 °C with 220 rpm
agitation, pelleted and resuspended in LB (OD600 of 1.0) and 20 µl samples were
spotted on MEA plates. After incubation at 37 °C for 20 h, the homogenized fungus
was sprayed on the MEA plates. The plates were sealed with paraﬁlm and incu-
bated in the dark at room temperature for 48 h. The antifungal activity of the
bacterial strains resulted in a fungus-free halo around the bacterial colony. Pictures
were taken with a Nikon D90 camera with an AF-S Micro Nikkor 60 mm objective.
Antifungal activity was deﬁned as areas (mm2) with no fungal growth surrounding
bacterial colonies and was calculated from pictures with the ImageJ software.
Assessment of promoter activity in liquid culture. Promoter activity of tran-
scriptional lacZ fusions in liquid cultures was assessed by β-galactosidase assays as
described before57 with minor modiﬁcations. Brieﬂy, bacterial cells were grown
overnight in ABG minimal medium. Where indicated, synthetic valdiazen or
(−)-fragin dissolved in methanol was added to the cultures. To assess the inﬂuence
of iron on promoter activity, no yeast extract was added to the ABG medium and
the FeCl3 was replaced with the concentrations indicated in the results section.
Bacterial overnight cultures were routinely adjusted to an OD600 of 2, centrifuged at
5000 rpm for 5 min and resuspended in 2 ml Z-buffer. A total of 1 ml bacterial
suspension was used to determine the exact OD600 value. To permeabilize the cell
membrane, 25 µl of chloroform and 0.1% SDS were added to the residual 1 ml of
bacterial suspension, vortexed for 10 s and incubated at 28 °C for 10 min. Overall,
200 µl of o-nitrophenyl-β-D-galactoside (ONPG) solution (4 mg/ml in Z-buffer)
were added to each sample, vortexed brieﬂy and incubated at room temperature.
The reaction was stopped by the addition of 500 µl 1M Na2CO3. The samples were
centrifuged at 16,000 rpm for 10 min and 1 ml of cell debris-free supernatant was
used to measure the absorbance at 420 nm and 550 nm. Speciﬁc activities (Miller
Units) are shown. To validate the cell density-dependent production of valdiazen,
growth (OD600) and promoter activity (Miller Units) was monitored throughout
the growth curve from samples collected every 2 h for a period of 28 h.
RNA-Seq and data analysis. For RNA extraction, 50 ml ABG aliquots were
inoculated from starter cultures (5 ml LB broth) with an OD600 of 0.03 and
incubated at 37 °C with agitation (220 rpm). Synthetic valdiazen resuspended in
methanol was added from the start to a ﬁnal concentration of 50 µM when
appropriate. An equal volume of methanol was added to all cultures not containing
synthetic valdiazen. The ﬁnal methanol concentration in all cultures was 0.1%.
Three independent cultures were grown to an OD600 of 0.9 to 1 and harvested,
using 1/10 of stop solution (10% phenol buffered with 10 mM Tris-HCl pH 8).
RNA extraction and genomic DNA removal were performed as previously
described58. A total of 150 ng good quality RNA (RNA integrity factor > 6) were
further processed (cDNA synthesis and library preparation) using the Ovation®
Complete Prokaryotic RNA-Seq Library System from NuGEN. After quantiﬁcation
of the obtained cDNA libraries59, Illumina single-end sequencing was performed
on a HiSeq2500 Instrument. The CLC Genomics Workbench v7.0 (QIAGEN CLC
bio, Aarhus, Denmark) was used to map the sequencing reads to the B. cenocepacia
H111 reference sequence60. Statistics and differential analysis was done using the
DESeq software61
Extraction of fragin and valdiazen. Bacterial strains were grown in ABG minimal
medium containing 0.005% yeast extract for 72 h with agitation (220 rpm) at 37 °C.
Bacterial cultures were centrifuged at 5000 rpm with an Eppendorf Centrifuge
5804R. To remove all bacterial cells, supernatants were subsequently ﬁltered with a
Millipore ExpressTm Plus 0.22 µm system. For fragin extraction, the cell free
supernatant was extracted twice with 0.5 equivalents v/v chloroform in a separation
funnel. The two chloroform phases were combined, dried with anhydrous mag-
nesium sulfate (Sigma-Aldrich, Switzerland), and ﬁltered through folded ﬁlters
(grade: 3 hw; Sartorius, Switzerland). The chloroform extracts were stored at 4 °C.
For valdiazen extraction, cell free supernatant was alkalized to a pH of 11 with 10
M NaOH and extracted twice with 0.5 volumes dichloromethane. The dichlor-
omethane phases were discarded and the water phase was subsequently acidiﬁed to
pH 5 with 10M HCl and extracted twice with 0.5 volumes dichloromethane. The
two dichloromethane phases were combined, dried using anhydrous magnesium
sulfate (Sigma-Aldrich, Switzerland) and ﬁltered. The dichloromethane extracts
were stored at 4 °C. Chloroform and dichloromethane extracts were dried using an
Eppendorf Concentrator 5301 under vacuum and routinely dissolved in 0.01
volumes methanol. The concentrated extracts were stored at −20 °C.
Analytical methods. All reactions were performed in dry solvents under an argon
atmosphere unless stated otherwise. The anhydrous solvents were obtained from
commercial suppliers and used without any puriﬁcation other than that they were
ﬁltered and passed through activated anhydrous alumina columns (Innovative
Technology solvent puriﬁcation system) prior to use. Syringes and stainless steel
cannula were used to transfer air and moisture sensitive liquids and solutions.
Analytical thin layer chromatography (Merck silica gel 60 F254 plates) was used to
monitor reactions and the compounds were detected by UV light (254 nm and 350
nm) and by staining using ceric ammonium molybdate (CAM) solution followed
by gentle heating with a heat gun. Flash chromatography was performed using
SiliCycle silica gel 60 (230–400 Mesh) and Rf values of compounds are indicated.
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NMR experiments were performed at 25 °C on a Varian Gemini Bruker DPX
operating at 400MHz, on a Bruker Avance III NMR spectrometer operating at 400
MHz proton frequency, a Bruker Avance III NMR spectrometer operating at 500
MHz proton frequency and at 126MHz carbon frequency, a Bruker Avance III
NMR spectrometer operating at 600.13 MHz proton frequency and 1H-decoupling
on a Varian Gemini 101MHz spectrometer. The spectra were calibrated using the
residual solvent proton and carbon signals (δH 7.26, δC 77.16 for CDCl3, and δH
3.31, δC 49.00 for CD3OD). Melting points (Mp) were determined using a Büchi B-
545 apparatus in open capillaries and are uncorrected. IR spectra were
recorded on a Varian 800 FT-IR ATR spectrometer or on a Spectrum Two (UATR)
FT-IR Spectrometer (Perkin Elmer) and data are reported in terms of
frequency of absorption (ν, per cm). Optical rotations were recorded on a Jasco P-
2000 digital polarimeter with a path length of 1 dm, using the 589.3 nm D-line of
sodium. Concentrations (c) are quoted in g/100 ml. High-resolution masses
(HRMS-ESI) were recorded on a Bruker max is 4G QTOF ESI mass spectrometer
or a QExactive instrument (Thermo Fisher Scientiﬁc, Bremen, Germany)
equipped with a heated electrospray (ESI) ionization source. HPLC puriﬁcations
were performed on a UHPLC Dionex Ultimate 3000 system equipped with an
Ultimate 3000 pump, an Ultimate 3000 autosampler, an Ultimate 3000 thermo-
stated column compartment and an Ultimate 3000 photodiode array detector or a
HPLC Agilent series 1100 equipped with a Quaternary pump, a degasser, an
autosampler, a thermostated column compartment and a VWD UV detector.
HPLC-MS analyses were performed on a Dionex HPLC system equipped with a
P680 pump, an ASI-100 automated sample injector, a TCC-100 thermostated
column compartment, a PDA-100 photodiode array detector and a MSQ-ESI mass
spectrometric detector. Lyophilization was performed using a Christ Alpha 1–2 LD
plus system.
X-ray crystal-structure analysis of the fragin–copper complex from the
University of Basel: data collection was performed at −150 °C using CuKα
radiation on a Bruker Kappa APEX diffractometer. Integration of the frames and
data reduction was carried out using the APEX2 software62. The structure was
solved by direct methods using SIR9263. All non-hydrogen atoms were reﬁned
anisotropically by full-matrix least-squares on F using CRYSTALS64.
X-ray crystal-structure analyses of (1) and (12) from the Univeristy of Zurich:
all measurements were made at −113 °C on an Agilent Technologies SuperNova
CCD area-detector diffractometer65 using CuKα radiation. Integration of the
frames and data reduction was carried out using CrysAlisPro65. The structures were
solved by direct methods using SHELXS-201366. All non-hydrogen atoms were
reﬁned anisotropically by full-matrix least-squares on F2 using SHELXL-201467.
Isolation of (−)-fragin (1). A comparison of the HPLC spectra of concentrated
extracts of B. cenocepacia H111 wild type and the hamD mutant identiﬁed a
compound, (−)-fragin (1), that is only present in the wild-type extract. The HPLC
analysis was performed using a reversed phase column (Phenomenex Gemini-NX
5 µm; 250 × 4.6 mm with ﬂow of 1 ml/min). The column was equilibrated for 5 min
with 20% MeCN/H2O and the MeCN/H2O applied gradient was changed from 2 to
100% MeCN in 25 min. The column was then washed with MeCN for 7 min. A
peak at 20.4 min was identiﬁed as (−)-fragin (1). The separation was achieved by
HPLC using a reversed phase column (Phenomenex Gemini-NX 5 µm; 250 × 4.6
mm with ﬂow of 1 ml/min). The column was equilibrated for 5 min
with 20% MeCN/H2O and the MeCN/H2O applied gradient was changed from 20
to 80% and ﬁnally to 100% MeCN in 15 and 1 min, respectively. The column was
then washed with MeCN for 8 min. A peak at 14.8 min was isolated and the
antifungal activity of this fraction was tested. The procedure was repeated using
multiple HPLC runs with the same conditions described above and (−)-fragin (1.4
mg) was obtained as a white solid. NMR experiments were performed in CDCl3
that was ﬁltered through aluminum oxide (activated, basic). (−)-Fragin (1.4 mg)
was dissolved in warm toluene (40 °C) and cooled slowly to RT to
obtain a single crystal, which was analyzed by X-ray crystallography. The absolute
conﬁguration of (−)-(R)-fragin (1) was determined by the crystal structure analysis
and by comparing the optical rotation values of the natural and synthetic
compound.
(−)-(R)-Fragin (1): white solid; MS (ESI): [M+H]+: 244.2 and 274.2; [M−H]−:
272.2; Optical rotation: [α]D –122° (c1.9, EtOH); 1H-NMR: (500MHz, CDCl3) δ=
11.72 (s, 1H), 5.69 (s, 1H), 4.20 (td, J= 9.2, 3.1 Hz, 1H), 3.86 (ddd, J= 14.4, 6.0, 3.1
Hz, 1H), 3.60 (ddd, J= 14.4, 9.4, 6.1 Hz, 1H), 2.25–2.17 (m, 1H), 2.14 (td, J= 7.4,
1.8 Hz, 2H), 1.61–152 (m, 2H), 1.31–1.23 (m, 8H), 1.07 (d, J= 6.8 Hz, 3H), 0.90 (d,
J= 6.7 Hz, 3H), 0.87 (t, J= 6.8 Hz, 3H); 13C NMR: (from HMQC, CDCl3) δ=
173.7, 78.0, 39.1, 36.6, 31.8, 29.3, 29.1, 29.1, 25.7, 22.7, 19.1, 18.9, 14.2 (as
determined from the 13C NMR of the synthetic compound).
Reactivity of the hydroxylamine 10a with sodium nitrite. To a solution of the
hydroxylamine 10a (1.4 µM, 0.5 ml) in MeOH, Na15NO2 (6.9 mg) and water (0.5
ml) were added. The solution was ﬁltered and analyzed by HPLC-MS (ESI positive
mode). Three data points were recorded: after the preparation of the sample, after
24 h and after 44 h.
Isolation of valdiazen (2). Concentrated valdiazen extracts were separated using
multiple RP-HPLC runs (Phenomenex Synergi Hydro-RP 4 µm; 250 × 4.6 mm, 40 °
C) at a ﬂow of 1 ml/min. The MeCN/aq. NH4OAc (20 mM, pH= 4) gradient
applied was changed from 2 to 50% and ﬁnally 50 to 100% in 15 and 7.1 min,
respectively. The column was then washed with MeCN for 4 min. Valdiazen, which
has a retention time of 10.2 min, was collected during each run. The fractions were
combined, rotary evaporated, dissolved in CH2Cl2 (5 ml), ﬁltered over wool and
evaporated to dryness to afford 0.5 mg of valdiazen (2) as a white solid.
Valdiazen (2): white solid: 1H-NMR (500MHz, MeOD): δ= 4.04–3.96 (m, 2H),
3.87–3.80 (m, 1H), 2.11 (ddh, J= 13.3, 7.2, 6.7, 1H), 1.02 (d, J= 6.8 Hz, 3H),
0.90 (d, J= 6.8 Hz, 3H); 13C-NMR: (126MHz, MeOD) δ= 82.2, 61.2, 29.3, 19.4,
19.4.
HPLC chiral separation of valdiazen (2). Valdiazen (2) was separated by HPLC
using a chiral column (Chiralpak OD-H 10 µm; 250 × 4.6 mm, 38 °C) at a ﬂow of
N0.8 ml/min. The hexane/EtOH isocratic gradient was 80%. Control samples of
pure (−)-valdiazen (12) eluted at 10.3 min, while (+)-valdiazen (13) eluted at 7.6
min. Two corresponding peaks at 10 min and 7.5 min were observed for valdiazen
(2).
Transcriptional lacZ fusions. DNA fragments containing the putative
promoters of the hamABCDE and hamFG operon were ampliﬁed with Phusion®
High-Fidelity DNA Polymerase (New England BioLabs Inc.) according to the
manufacturer’s instructions using the primers listed in Supplementary Data 5.
Annealing temperatures were calculated with the NEB Tm calculator online pro-
gram (New England BioLabs Inc.). The promoter fragments were separated on
agarose gels, excised and puriﬁed with the QIAquick gel extraction kit
(Qiagen). The puriﬁed fragments were digested with the restriction enzymes (New
England BioLabs Inc.) indicated in Supplementary Data 5 according to the man-
ufacturer’s instructions and puriﬁed by the QIAquick PCR puriﬁcation kit (Qia-
gen). The lacZ-fusion vector pSU1168 was digested with the restriction enzymes
XhoI and HindIII (New England BioLabs Inc.) according to the manufacturer’s
instructions and subsequently puriﬁed by the QIAquick PCR puriﬁcation kit
(Qiagen). The promoter fragments were ligated into pSU11 with T4 ligase (New
England BioLabs Inc.) according to the manufacturer’s instructions. The resulting
plasmids were electroporated into E. coli Top10 and subsequently transferred into
the target strain by tri-parental mating and selected on PIA plates containing
gentamycin (20 µg/ml).
Quantitative real-time PCR. RNA was extracted from B. cenocepacia
H111 wild type and ΔhamD cells grown to late exponential phase in ABG medium,
as previously described69 and further puriﬁed using the RNeasy Qiagen kit (Qia-
gen, Germany). First strand cDNA was synthesized using random primers (Invi-
trogen, USA) and MLV reverse transcriptase (Promega, USA). qPCR was
performed on the generated cDNA using Brilliant III Ultra-Fast SYBR® Green
QPCR Master Mix (Agilent, USA) and a Mx3000P instrument (Agilent, USA).
Primers used are listed in Supplementary Data 5. Each PCR reaction was run in
triplicate and melting curve data was analyzed to determine the PCR speciﬁcity.
Relative expression levels of several differentially regulated genes from the RNA-
seq data were calculated using the ΔΔ CT method70 and the rpoD gene was used as
the reference gene for normalization.
Construction of plasmids for the complementation of mutants. Plasmids for
complementation purposes were constructed by PCR of the respective gene using
the Phusion® High-Fidelity DNA Polymerase (New England Biolabs Inc). For all
genes, except hamB, the ampliﬁed fragment included the predicted ribosome
binding site (RBS) of the gene. The 5′-end of hamB overlaps with the 3′-end of
hamA and does not have its own RBS; therefore, a synthetic RBS was introduced
with the forward primer upstream of the start codon of hamB. All primers used for
the construction of these plasmids are listed in Supplementary Data 5. The
annealing temperatures for the PCRs were calculated with the NEB Tm calculator
online program (New England BioLabs Inc.). The ampliﬁed fragments were
separated on agarose gels, excised and puriﬁed with the QIAquick gel extraction kit
(Qiagen). The puriﬁed fragments were digested with the restriction enzymes (New
England BioLabs Inc.) indicated in Supplementary Data 5 according to the man-
ufacturer’s instructions and again puriﬁed by the QIAquick PCR puriﬁcation kit
(Qiagen). The expression vector pBBR1MCS2 was digested with the restriction
enzymes HindIII and XbaI (New England BioLabs Inc.; expression of hamA, hamB,
hamD, hamF, and hamG) or XhoI and XbaI (New England BioLabs Inc.; expres-
sion of hamC and hamE) according to the manufacturer’s instructions and sub-
sequently puriﬁed by the QIAquick PCR puriﬁcation kit (Qiagen). The promoter
fragments were ligated into pSU11 with T4 ligase (New England BioLabs Inc.)
according to the manufacturer’s instructions. The resulting plasmids were elec-
troporated into E. coli Top10 and subsequently transferred into the target strain by
tri-parental mating.
Plasmid transfer. Plasmids were transferred from E. coli to B. cenocepacia strains
by tri-parental mating using E. coli HB101/pRK600 as the helper strain as described
previously71. E. coli strains (donor and helper strain) and B. cenocepacia (recipient
strain) were grown in LB overnight with agitation (220 rpm) at 37 °C. The donor
and helper strains were mixed and incubated at room temperature for 10 min
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before the recipient strain was added. The bacterial mixture was then spotted on LB
agar plates and incubated at 37 °C for 4 to 7 h, washed off with saline (0.9% NaCl
solution) and plated on Pseudomonas Isolation Agar (PIA; BDTmDifco, USA)
containing appropriate antibiotics and incubated overnight at 37 °C. Transconju-
gants were veriﬁed by PCR using the primers listed in Supplementary Data 5.
HamC protein puriﬁcation and enzyme assay. The hamC gene was ampliﬁed
with Phusion® High-Fidelity DNA Polymerase (New England BioLabs Inc.) using
the primers listed in Supplementary Data 5. The resulting PCR product
was puriﬁed from an agarose gel by the QIAquick gel extraction kit (Qiagen),
digested with the restriction enzymes indicated in Supplementary Data 5, and
cloned into pQE30. The resulting plasmid, pQEhamC (Supplementary Table 6),
was electroporated into E. coli M15. 200 ml LB were inoculated with an overnight
culture of E. coli M15 pQEhamC to an OD600 of 0.02 and grown with
agitation (220 rpm) at 37 °C. After 3 h of growth, the cultures were shifted to 30 °C
and the expression of his-tagged HamC was induced with 500 µM IPTG. Every
hour, starting at the induction, 100 µM ferrous ammonium sulfate was
added to the cultures to ensure incorporation of iron into the protein. After 3 h, the
cells were centrifuged (3000×g, 4 °C, 10 min) and the pellet was frozen in liquid
nitrogen and stored at −80 °C. For protein puriﬁcation, the cells were thawed on
ice and resuspended in 5 ml lysis buffer (100 mM NaH2PO4; 500 mM NaCl, 5 mM
Imidazol; 10% Glycerol; pH8) containing protease inhibitor (Roche Protean Tablet
EDTA free) and lysed with a French press at 2 kBar. The cell lysate was
centrifuged at 10,000×g at 4 °C for 60 min. Puriﬁcation of his-tagged HamC was
performed with ProﬁnityTM IMAC Resin (BioRad) according to the manufacturer
instructions with slight modiﬁcations. In brief, the lysate was incubated with
washed resin for 60 min at 4 °C with shaking, centrifuged (1000×g, 4 °C, 2 min) and
washed twice with washing buffer (50 mM NaH2PO4, 500 mM NaCl, 30 mM
Imidazol, pH8). The pellet was resuspended in 500 µl elution buffer (50 mM
NaH2PO4, 500 mM NaCl, 250 mM Imidazol, pH8) and centrifuged (1000×g, 4 °C,
2 min). The supernatant was collected, ﬂash frozen with liquid nitrogen and stored
at −80 °C. The elution step was repeated three times and the collected supernatants
pooled. Washing and elution steps of his-tagged HamC were examined by SDS-
PAGE and Coomassie blue staining. The eluted protein was subsequently con-
centrated and the buffer exchanged (25 mM MOPS, 400 mM NaCl, pH7) using
Amicon Ultra Centrifugal Filter Units (NMWL 10 kDa) (EMD MILLIPORE). The
purity of the concentrated protein was estimated by SDS-PAGE and the protein
concentrations were determined with Bradford Reagent (Sigma-Aldrich).
Enzyme activity. The enzymatic activity of puriﬁed HamC was studied as pre-
viously described for PsAAO38 with modiﬁcations. To a solution of water
(76.1 µl), PABA (12.5 µl, 40 mM in DMSO), NaCl (1.8 µl, 1 M in H2O), MOPS (2.3
µl, 1 M in H2O) and a solution of the enzyme HamC (6.4 µl) in MOPS buffer (25
mM) with NaCl (100 mM) were sequentially added. To start the reaction H2O2 (5
µl, 30% in H2O) was added and the reaction was analyzed by HPLC-MS after 1 day.
A control experiment was performed using water instead of the enzyme solution.
Chemogenomic proﬁling including HIP and HOP. The growth-inhibitory
potency of test substances was determined using wild type S. cerevisiae
BY4743. OD600 values of exponentially growing cultures in rich medium were
recorded with a robotic system. Twelve-point serial dilutions were assayed in 96-
well plates with a reaction volume of 150 µl, start OD600 was 0.05. Solutions
containing dimethyl sulfoxide (DMSO) were normalized to 2%. IC30 values were
calculated using logistic regression curve ﬁts generated by TIBCO Spotﬁre v3.2.1
(TIBCO Software Inc.). HIP, HOP, and microarray analysis were performed as
described previously30. Sensitivity was computed as the median absolute deviation
logarithmic (MADL) score for each compound/concentration combination.
z-scores are based on a robust parametric estimation of gene variability from over
3000 different proﬁlings and were computed as described in detail in Hoepfner
et al.30
Quantiﬁcation of valdiazen. The concentration of valdiazen (2) in the super-
natant of the H111 wild type and the H111 ΔhamF strain was determined by
UHPLC/MS measurements (ultimate 3000 system equipped with a Kinetex® EVO
C18; 1.7 µm; 100 Å, 50 × 2.1 mm as the column, a ﬂow of 0.4 ml/min and a solvent
system consisting of MeCN/H2O (both containing 0.1% formic acid)). The gradient
used varied from 2 to 2% in 0.9 min, 2 to 30% in 0.3 min, 30 to 95% in 2.3 min, 95
to 100% in 0.05 min and the column was washed with 100% MeCN for 1.24 min.
The samples used for the calibration curve were composed of four aqueous solu-
tions of the synthetic valdiazen (Supplementary Methods) at 10, 20, 50, and 100 µg/
ml and 1 µl was injected. The supernatants of the H111 wild type and the H111
ΔhamF mutant were ﬁltered and 2 µl were injected. For the quantiﬁcation, the
chromatograms at wavelengths between 240 and 250 nm were analyzed and, to
conﬁrm the identity of the peak, SIM measurements at 149.1 Da were performed. A
valdiazen concentration of 6.0 µg/ml (41 µM) was calculated in the supernatant of
the H111 ΔhamF mutant and 3.3 µg/ml (22 µM) in the supernatant of the H111
wild-type strain.
Quantiﬁcation of (−)-fragin. The quantiﬁcation of fragin (1) in the supernatant
of the H111 wild type strain was performed as described for the quantiﬁcation of
valdiazen with some modiﬁcations. The solvent system of the UHPLC was
composed of MeCN/H2O (both containing 0.1% formic acid), the column was
equilibrated at 30% for 0.4 min, the gradient was varied from 30 to 95% in 2.1 min,
95 to 100% in 0.05 min and the column was washed with 100% MeCN for 1.24
min. The samples used for the calibration curve were composed of synthetic fragin
(Supplementary Methods) solutions (H2O/MeCN 1/1) from 50, 100, 200 and 500
µg/ml and 1 µl of these samples and the supernatant of H111 wild-type strain were
injected. The quantiﬁcation was done using the SIM chromatograms at 244.1 Da.
The concentration of fragin was calculated to be 69 µg/ml (253 µM) in the
supernatant of the H111 wild-type strain.
Statistical analysis. Statistical signiﬁcance for differences of antifungal activity in
dual-culture plate assays was calculated with either one-way ANOVA and Tukey’s
multiple comparison as a post test or a paired two-tailed Student’s t-test. Differ-
ences were considered signiﬁcant with p < 0.05.
Data availability. Crystallographic data have been deposited in the Cambridge
Crystallographic Data Centre (www.ccdc.cam.ac.uk/structures) with accession
codes CCDC-1543487, CCDC-1543488, and CCDC-1812456. The RNA-Seq raw
and processed data have been deposited in the GEO database with accession code
GSE97171. The authors declare that all other data supporting the ﬁndings of this
study are available in this article and its Supplementary Information ﬁles, or from
the corresponding authors upon request.
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